Minerva Neurosciences Inc

(NERV) Trade

By |

Profile

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. The company primarily focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. This portfolio includes four compounds, schizophrenia, insomnia, major depressive disorder and Parkinson's disease. Its product portfolio and potential indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

Contact Information

Website: www.minervaneurosciences.com
Email: wboni@minervaneurosciences.com
Main Phone: +1 617 600-7373
Address: 1601 Trapelo Road
Address 2: Suite 286
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02451

Issuer Information

Exchange: NSD
CEO: Remy Luthringer
Employees: 14
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 7.14 $ 0. (0.00%)
Last Price 7.14 Change $ 0. Change % 0.00 Tick N/A
Bid 5.86 Bid Size 100.00 Ask 9.90 Ask Size 500.00
Open N/A High N/A Low N/A Prev Close 7.14
Last Trade Volume 0 52 Wk Hi 12.95 52 Wk Low 5.00
Market Cap 277.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 38,871,467.00 EPS (TTM) -0.94 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 8
Number of Buys 0 4
Number of Sells 0 4
Net Activity 0 32410
Last 10 Buys Shares
Marc D. Beer 1,000
Marc D. Beer 1,000
David J. Kupfer 1,000
David J. Kupfer 1,000
David J. Kupfer 1,000
Francesco De Rubertis 1,000
Michèle Ollier 1,000
Last 10 Sell Shares
Remy Luthringer 1,000
Frederick W. Ahlholm 1,000
Joseph Reilly 1,000
Geoff Race 1,000
Mark S. Levine 1,000
Frederick W. Ahlholm 1,000
Frederick W. Ahlholm 1,000
Remy Luthringer 1,000
Geoff Race 1,000
Remy Luthringer 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 11 11 11 11
Mean Target Price Estimate 14.5 14.5 14.5 14.5
Standard Deviation 4.95 4.95 4.95 4.95
Date of Most Recent Estimate 03/12/18 03/12/18 03/12/18 03/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1